Skip to main content
. 2012 Apr 18;53(4):217–228. doi: 10.4111/kju.2012.53.4.217

TABLE 2.

Results of targeted therapy for metastatic renal cell cancer (RCC) in Korea

graphic file with name kju-53-217-i002.jpg

Values are presented as number (%).

MSKCC, Memorial Sloan-Kettering Cancer Center risk group; PFS, progression-free survival; OS, overall survival.